Pimagedine

Pimagedine

SCHEMBL19123

Cl.NN=C(N)N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Pimagedine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pimagedine SCHEMBL4915680 1.00
Pimagedine SCHEMBL28034548 0.94
Pimagedine SCHEMBL57796 0.94
Pimagedine SCHEMBL3818924 0.89
Pimagedine SCHEMBL28267236 0.89
Pimagedine SCHEMBL8576821 0.89
Pimagedine SCHEMBL28893570 0.89
Pimagedine SCHEMBL7941763 0.77
Pimagedine SCHEMBL439904 0.77 BLM (1.00)
Pimagedine SCHEMBL5968075 0.77 BLM (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2239 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4719593-A1 ENANTIOSELECTIVE PREPARATION METHOD Immunahr AB (SE) 2026-04-08 EP claimed
US-20250223163-A1 CARBON NITRIDES WITH HIGHLY CRYSTALLINE FRAMEWORK AND PROCESS FOR PRODUCING SAME THE UNIVERSITY OF NEWCASTLE (AU) 2025-07-10 US claimed
EP-4565367-A1 CARBON NITRIDES WITH HIGHLY CRYSTALLINE FRAMEWORK AND PROCESS FOR PRODUCING SAME The University of Newcastle (AU) 2025-06-11 EP claimed
CN-120004697-A Preparation method of OrgVO material and application of OrgVO material as secondary battery anode material 同济大学 2025-05-16 CN claimed
CN-119753848-A Amino guanidine oxalate second-order nonlinear optical crystal material, preparation and application thereof 同济大学 2025-04-04 CN claimed
CN-119688807-A Method for measuring HAN and hydroxyethyl hydrazine nitrate content in hydroxylamine nitrate propellant 中国科学院大连化学物理研究所 2025-03-25 CN claimed
CN-119591372-A Carbon mineralized artificial stone based on solid waste and preparation process thereof 苏州同萃碳中和科技有限公司 2025-03-11 CN claimed
CN-119570279-A Environment-friendly composite plastic-wood board and preparation method thereof 美新科技股份有限公司 2025-03-07 CN claimed
CN-119285811-B Guanidine-containing carboxymethyl chitosan quaternary ammonium salt derivative and preparation method and application thereof 中国科学院烟台海岸带研究所 2025-02-25 CN claimed
CN-119503795-A Modified activated carbon, silicon-carbon composite material, preparation method thereof, pole piece, application and electrochemical device 上海杉杉新材料有限公司 2025-02-25 CN claimed
WO-1996013490-A1 IMPROVED PROCESS FOR THE PREPARATION OF 5-AMINOTETRAZOLE OLIN CORPORATION (US) 1996-05-09 WO claimed
US-5424449-A Reacting aminoguanidine salt of mineral acid with a diazotization agent to form guanylazide salt; cyclization OLIN CORPORATION (US) 1995-06-13 US claimed
EP-0636023-A1 AMINOGUANIDINE SPRAY DRYING PROCESS HOECHST MARION ROUSSEL, INC. (US) 1995-02-01 EP claimed
EP-0283876-B1 Substituted triazolinones BAYER AG (DE) 1994-07-20 EP claimed
WO-1993020808-A1 AMINOGUANIDINE SPRAY DRYING PROCESS MARION MERRELL DOW INC. (US) 1993-10-28 WO claimed
US-5128360-A Inhibition of advanced glycosylation end products of target proteins using aminoguanidine and-or hydrazinohistidine THE ROCKEFELLER UNIVERSITY (US) 1992-07-07 US claimed
EP-0448228-A2 Aminoguanidine assay and applications thereof ALTEON INC. (US) 1991-09-25 EP claimed
EP-0305844-A1 Substituted triazolinones BAYER AG (DE) 1989-03-08 EP claimed
EP-0283876-A2 Substituted triazolinones BAYER AG (DE) 1988-09-28 EP claimed
US-4149980-A AMINOGUANIDINE SULFONATE OVERBASED COMPOUND STANDARD OIL COMPANY (INDIANA) (US) 1979-04-17 US claimed